logo
Angel One shares rally 5% on announcing Rs 26 dividend despite Q4 profit slump. Here's what brokerages say

Angel One shares rally 5% on announcing Rs 26 dividend despite Q4 profit slump. Here's what brokerages say

Economic Times21-04-2025

Live Events
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
Shares of Angel One climbed as much as 5.4% on Monday to Rs 2,483.75 on the BSE after the stockbroker firm announced a final dividend of Rs 26 per share for FY25, despite posting a sharp decline in quarterly profit and revenue.The broking firm's consolidated net profit for the January–March quarter fell 48.7% year-on-year to Rs 174.5 crore, while revenue declined 22.2% to Rs 1,056 crore. Operating margins also contracted to 32.5% from 39% in the same period a year ago, with EBITDA dropping 35.3% to Rs 342.8 crore.ICICI Securities downgraded the stock to "Add" from "Buy" and cut its target price to Rs 2,500 from Rs 3,000, citing an expected earnings trough in the first half of FY26 due to weak market conditions and regulatory headwinds. The revised target implies a potential upside of about 0.7% from Monday's high.The brokerage said it expects a rebound in Angel One's earnings with a projected PAT of Rs 8.3 billion in FY26, and Rs 12.5 billion in FY27. Over the longer term, ICICI Securities sees potential for significant recovery, projecting a PAT of Rs 15 billion by FY27E.HDFC Securities, however, maintained a 'Buy' rating and set a target price of Rs 2,850, implying a potential upside of nearly 15% from current levels. 'Net revenue and PAT collapsed 31% and 60% versus Q2 FY25, while high acquisition costs and IPL-related spends also took a toll,' HDFC Securities said in a research note. 'We believe F&O activity has now stabilised and is likely to start improving on a sequential basis.'Angel One's Q4 performance reflected the full impact of regulatory changes in the equity derivatives segment, with average daily orders declining to 5.3 million from a peak of 8.8 million in June 2024. F&O orders dropped 25.6% quarter-on-quarter, according to ICICI Securities.The company also reported a 5.5% sequential drop in its margin trading funding (MTF) book to Rs 38.5 billion and a 10.2% fall in total borrowings to Rs 33.8 billion. Interest income declined 3.3% quarter-on-quarter to Rs 3.4 billion.Despite the weak quarter, Angel One's leadership highlighted strong annual performance. Chairman and Managing Director Dinesh Thakkar said FY25 was a 'transformative year,' while Group CEO Ambarish Kenghe noted the company achieved record client additions and its highest-ever annual profit.Angel One's board has recommended the Rs 26 per share final dividend, to be paid within 30 days of the Annual General Meeting. The stock remains down 29% from its 52-week high of Rs 3,502.60 hit in December.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

From Rs 25,000 monthly salary to Rs 5 crore savings in 11 years: How a middle-class employee achieved his dream
From Rs 25,000 monthly salary to Rs 5 crore savings in 11 years: How a middle-class employee achieved his dream

Time of India

time36 minutes ago

  • Time of India

From Rs 25,000 monthly salary to Rs 5 crore savings in 11 years: How a middle-class employee achieved his dream

Inspired by Long-Term Investing Crisis as an Opportunity Living Within Means and Planning Ahead Avoiding Common Pitfalls Achieving financial independence on a modest salary may seem out of reach for many middle-class professionals. But over 11 years, one salaried individual steadily built a net worth of Rs 5 crore—without inheritance, business income, or sudden windfalls. His journey, shaped by disciplined saving, long-term investing, and strategic career choices, offers practical insights for anyone looking to grow wealth from 2013, a middle-class employee began his career with Rs 25,000 monthly salary. From the very beginning, he set aside 25% of his income as savings. His financial discipline grew stronger after he shifted back to his hometown, eliminating rental expenses and increasing his savings rate to 75%. By 2024, this approach helped him build a net worth of Rs 5 crore—a milestone he called his biggest achievement of the his entire financial journey on the INDmoney YouTube channel, he credited this financial transformation to three key factors: prioritising career growth to increase his income, practising delayed gratification, and staying committed to equity investing. Importantly, he noted that having no debt and not paying rent gave him a significant head start.A defining moment in his investment journey came during his stint as a wealth manager. There, he came across an ITC employee whose employee stock options had grown into a Rs 5 crore corpus over two decades. This real-life example solidified his faith in the power of long-term equity investing and compounding entered the stock market in 2013–14, gradually building a portfolio that yielded annualised returns of around 18–20%. His stock-picking approach centred on small companies in growing industries, avoiding highly saturated market leaders. He preferred businesses that generated healthy cash flows, had minimal debt, and avoided red flags like promoter pledging or frequent equity 2020 market crash proved to be a turning point. His portfolio fell by 45% during the COVID crisis. Instead of panicking, he doubled down and bought more stocks as the Nifty Index dropped to the 8,000–10,000 range. This aggressive move paid off, helping his portfolio recover strongly in the following 90% of his assets are in equities, while the remaining 10% is split between cash, NPS, and EPF. He has also started exploring passive income sources such as REITs and infrastructure investment trusts, including IndiGrid, which offers nearly 10% achieving a high net worth, he remains cautious about early retirement. His current monthly expenses stand at Rs 1–1.2 lakh, and he believes that Rs 5 crore may not be enough to sustain financial independence in the long term, especially with rising education and lifestyle also highlighted how pursuing an MBA helped boost his income significantly, compared to peers who joined the workforce right after engineering. In his early years, he opened a PPF account and delayed luxury purchases, even buying his first iPhone only after accumulating a Rs 10 lakh back, he cautioned against getting swayed by investment fads like cryptocurrencies or bankrupt stocks. He emphasized the importance of building a solid foundation first and sticking to long-term fundamentals. In one of his online interactions, he underlined that staying invested for the long run was far more effective than trying to time the summed up his philosophy by saying that while investing is undoubtedly challenging, the long-term grind of working 9 to 5 for 40 years is even harder.

Compliance review: Sun Pharma's Halol plant gets 8 USFDA observations; company vows remedial steps after inspection
Compliance review: Sun Pharma's Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

Time of India

time39 minutes ago

  • Time of India

Compliance review: Sun Pharma's Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

Sun Pharmaceutical Industries Ltd on Saturday said the US Food and Drug Administration (USFDA) has issued a Form 483 with eight observations following an inspection of its Halol manufacturing facility in Gujarat. Tired of too many ads? go ad free now The inspection, which focused on Good Manufacturing Practices (GMP), was conducted between June 2 and June 13, 2025, the company said in a regulatory filing to the stock exchanges. 'At the conclusion of the inspection, the USFDA issued a Form-483 with 8 observations,' Sun Pharma stated as quoted PTI. A Form 483 is issued by the US health regulator to a company's management when an investigator observes conditions that may violate the Food Drug and Cosmetic (FD&C) Act and associated regulations. Such observations are not final determinations, but they typically require prompt corrective action and a written response from the manufacturer. Sun Pharma did not disclose the nature of the observations but is expected to submit a comprehensive remediation plan in line with regulatory protocol. Meanwhile, the drug major reported a 19% year-on-year (YoY) decline in consolidated net profit for the March quarter FY 2024-25, which stood at Rs 2,154 crore compared to Rs 2,659 crore in the same period last year. Revenue from operations, however, rose 8% YoY to Rs 12,959 crore, up from Rs 11,983 crore in Q4FY24. On a sequential basis, both profit and revenue decreased. Profit after tax (PAT) dropped 26% from Rs 2,913 crore in Q3FY25, while revenue fell 5% from Rs 13,675 crore in the previous quarter. For the full financial year, net profit increased to Rs 10,965 crore from Rs 9,610 crore in FY24. Meanwhile, revenue grew by 8.5% to Rs 52,578 crore in FY25, up from Rs 48,497 crore the previous year.

ITC completes acquisition of 24 Mantra Organic brand owner Sresta Natural
ITC completes acquisition of 24 Mantra Organic brand owner Sresta Natural

Business Standard

timean hour ago

  • Business Standard

ITC completes acquisition of 24 Mantra Organic brand owner Sresta Natural

Multi-conglomerate ITC has completed the acquisition of Sresta Natural Bioproducts, which owns the '24 Mantra Organic brand' in an all-cash deal valued at Rs 472.50 crore. This will help ITC to expand its play in the fast-growing organic food products segment. The company has completed the acquisition of 100 per cent of the share capital of SNBPL on 13th June, 2025, ITC said in a regulatory filing. On the acquisition cost, ITC said it had an upfront consideration of Rs 400 crore on a cash-free debt-free basis and addition, consideration of up to Rs 72.50 crore, which is payable in the next 24 months. In April ITC had informed it had signed a share purchase agreement with Sresta Natural Bioproducts Private Limited (SNBPL) to acquire 100 per cent stake in the company. This acquisition is "in line with the strategy to augment the company's future-ready portfolio, the transaction is expected to fortify ITC's presence and market standing in the high-growth organic products segment in both Indian and overseas market, the Kolkata-headquartered firm said. SNBPL's portfolio comprises a wide range of over 100 organic products, spanning branded grocery staples, spices and condiments, edible oils, and beverages, among others. Besides, it has a strong international presence with a deep connection with the Indian diaspora. The domestic organic food products industry offers a "significant opportunity" for growth on the back of increasing health and environmental consciousness, a rise in household incomes and new-age distribution channels, ITC said, adding that SNBPL is a pioneer and leading player in the organic packaged staples category. SNBPL has two wholly-owned subsidiaries -- Fyve Elements LLC, USA and Sresta Global FZE, UAE. SNBPL, incorporated in March 2004, recorded a revenue of Rs 306.1 crore in FY 2023-24. Over the years, it has built a strong network of approximately 27,500 farmers and 1.4 lakh acres of certified organic land across 71 clusters in 10 states.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store